Preclinical Study and Clinical Correlation of The Effect of PEP2DIA® Dose | ||
| Egyptian Society of Diabetes and Lipidology Journal | ||
| Volume 2, Issue 1, April 2022 PDF (67.21 K) | ||
| Document Type: Abstracts | ||
| DOI: 10.21608/esdlj.2022.455714 | ||
| Abstract | ||
| Prediabetes is a reversible phase of glycemic dysregulation that occurs before type 2 diabetes (T2D). It is therefore important to take in charge prediabetics before they reach diabetic stage. PEP2DIA® is a unique patented dairy bioactive that acts on the main factors leading to T2D. | ||
|
Statistics Article View: 26 PDF Download: 8 |
||
